Literature DB >> 8903617

Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke.

S Ueda1, C J Weir, G C Inglis, G D Murray, K W Muir, K R Lees.   

Abstract

AIM: The human angiotensin converting enzyme (ACE) gene is a candidate genetic locus for stroke because of the importance of the renin-angiotensin system to the development of cardiovascular disease. In the present study, the association between ACE gene deletion/insertion (D/I) polymorphism and the presence or absence of ischaemic stroke was evaluated and possible associations between ACE gene polymorphism and certain subgroups of stroke were investigated.
MATERIALS AND METHODS: DNA samples from 585 unselected suspected stroke patients admitted to the Acute Stroke Unit, Western Infirmary, Glasgow, and from 188 age- and sex-matched controls were genotyped by polymerase chain reaction.
RESULTS: There was no evidence of any association between ACE gene polymorphism and the presence of ischaemic stroke except in the subgroup containing only hypertensive patients, where the odds ratio of a DD genotype for ischaemic stroke was just significantly greater than 1 (odds ratio 2.51, 95% confidence interval 1.06, 5.94). There was no significant association between ACE genotype and the stroke subgroups investigated.
CONCLUSION: The DD genotype may not be a risk factor for stroke, particularly in the normotensive population. Further study in a strictly controlled population is required to test for the possibility of an increased risk of stroke in hypertensives with DD homozygotes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8903617

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

Review 1.  Catecholamines and angiotensinogen gene expression in kidney proximal tubular cells.

Authors:  J S Chan; T T Wang; S L Zhang; X Chen; S Carrière
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Meta-analysis of the ACE gene in ischaemic stroke.

Authors:  P Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

3.  Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans.

Authors:  J Y Um; H J Kim; T J Choi; C S Jin; S T Park; K C Lee; H S Rhee; K M Lee; Y M Lee; H M Kim; N H An; J J Kim
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

4.  Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

5.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 6.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

7.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies.

Authors:  Zhizhong Zhang; Gelin Xu; Dezhi Liu; Xinying Fan; Wusheng Zhu; Xinfeng Liu
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

8.  Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer's type in an elderly Arab population in Wadi Ara, Israel.

Authors:  Abdalla Bowirrat; Jing Cui; Kristin Waraska; Robert P Friedland; Marlene Oscar-Berman; Lindsay A Farrer; Amos Korczyn; Clinton T Baldwin
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

9.  Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke.

Authors:  Sanja Stankovic; Aleksandra Stankovic; Milika Asanin; Zagorka Jovanovic-Markovic; Dragan Alavantic; Nada Majkic-Singh
Journal:  EJIFCC       Date:  2011-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.